BackOxford Immunotec Global PLC Overview

Oxford Immunotec Global PLC Common Stock

Latest common stock for OXFD: $270K.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$272000.00
2.16% YoYΔ $-6000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Oxford Immunotec Global PLC Common Stock History

Loading

Oxford Immunotec Global PLC vs. peers: Common Stock Comparison

Loading

Oxford Immunotec Global PLC Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Oxford Immunotec Global PLC (OXFD) FAQ

Oxford Immunotec Global PLC's common stock stands at $270K as of September 2020. That compares with $280K in the prior-year period — down 2.2% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Oxford Immunotec Global PLC reported $270K in common stock versus $280K a year earlier — a 2.2% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $280K in the prior-year period — down 2.2% year over year. Sustained growth in common stock can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Oxford Immunotec Global PLC's common stock evolved across reporting periods, while the comparison chart places OXFD next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, common stock is commonly used to spot outliers. Oxford Immunotec Global PLC's reading of $270K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.